Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pseudomixoma peritonei: a case report

F Cafiero1, A Peressini, S Bertoglio

  • 1Department of Surgical Oncology, University of Genoa, Italy.

Anticancer Research
|January 15, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cabozantinib plus nivolumab and ipilimumab in previously untreated, advanced renal cell carcinoma: final results and biomarker analyses from the phase III COSMIC-313 study.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Randomized, double-blind, phase III LEAP-003 study of first-line lenvatinib plus pembrolizumab versus placebo plus pembrolizumab for unresectable or metastatic melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology.

ESMO open·2024
Same author

Reply to: Femoral site for implantation of a port-a-catheter in a cancer patient.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2024
Same author

Guidelines for the diagnosis and treatment of basal cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology.

ESMO open·2023
Same author

Predictors of germline status for hereditary melanoma: 5 years of multi-gene panel testing within the Italian Melanoma Intergroup.

ESMO open·2022
Same journal

Corrigendum.

Anticancer research·2026
Same journal

Geographic Variation in Stage at Diagnosis of Skin Cancer in the United States: A National Cancer Database Analysis.

Anticancer research·2026
Same journal

Anti-tumor Effects of Loureirin A Treatment in Colorectal Cancer Cells <i>via</i> Inhibition of AKT Phosphorylation.

Anticancer research·2026
Same journal

Bayesian Analysis to Refine East Asian Subgroup Estimates in the CLEAR Trial (Lenvatinib Plus Pembrolizumab <i>vs</i>. Sunitinib) for Advanced Renal Cell Carcinoma.

Anticancer research·2026
Same journal

Pulsed Electromagnetic Field Increases Doxorubicin-induced Mitotic Slippage in MDA-MB-231 Breast Cancer Cells.

Anticancer research·2026
Same journal

Geographic Disparities in Socioeconomic Factors and Advanced-stage Presentation in Rectosigmoid Cancer: A National Cancer Database Analysis.

Anticancer research·2026
See all related articles

Pseudomyxoma peritonei, a rare mucinous neoplasm, presents diagnostic challenges due to non-specific lab and radiology results. This case highlights cytoreductive surgery and omentectomy as key treatments.

Area of Science:

  • Oncology
  • Gastroenterology
  • Pathology

Background:

  • Pseudomyxoma peritonei is a rare condition involving mucinous ascites and peritoneal surface involvement.
  • It is typically associated with mucinous tumors of the appendix or ovary.
  • Diagnosis is often challenging due to non-specific laboratory and radiological findings.

Observation:

  • This report details a case initially misdiagnosed as carcinomatosis of unknown origin.
  • The patient presented with characteristic mucinous ascites and peritoneal involvement.
  • Diagnostic difficulties were encountered due to ambiguous initial test results.

Findings:

  • Pseudomyxoma peritonei was confirmed despite initial misdiagnosis.
  • The condition involved extensive mucinous infiltration of the peritoneum, omentum, and bowel loops.

Related Experiment Videos

  • Histopathological examination confirmed the mucinous nature of the neoplasm.

    • Implications:

    • Accurate and timely diagnosis of pseudomyxoma peritonei is crucial for effective treatment.
    • Cytoreductive surgery and omentectomy represent a viable treatment strategy.
    • Increased awareness and improved diagnostic modalities are needed for this rare neoplasm.